Moffitt Cancer Center, Tampa — Tampa, Florida

Moffitt Cancer Center, Tampa is a clinical research site located in Tampa, Florida, United States 33612.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Moffitt Cancer Center, Tampa has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer).

Sponsors: Acerand Therapeutics (Hong Kong) Limited.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Moffitt Cancer Center, Tampa?

Moffitt Cancer Center, Tampa has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Moffitt Cancer Center, Tampa conducted?

Moffitt Cancer Center, Tampa has 1 clinical trials on record, with 1 currently active. Their work covers Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer).

Is Moffitt Cancer Center, Tampa accredited by Crixeo Health?

Moffitt Cancer Center, Tampa has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Moffitt Cancer Center, Tampa?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.